Skip to main content

Table 2 Outcome of Kaposi sarcoma patients with IRIS and non-IRIS; treated with chemotherapy or without it, at time of last follow-up

From: Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma

 

IRIS-KS (N = 35)

Non-IRIS-KS (N = 54)

Total (N = 89)

CR

PR

Death

CR

PR

Death

CR

PR

Death

Chemotherapy—N (%)

19 (54)

3 (9)a

9 (26)

15 (28)

0

2 (4)

34 (38)

3 (3)

11 (12)

No-chemotherapy N (%)

4 (11)

0

0

33 (61)

1 (2)

3 (5)

37 (42)

1 (1)

3 (3)

Total, N (%)

23 (65)

3 (9)

9 (26)

48 (89)

1 (2)

5 (9)

71 (80)

4 (4)

14 (16)

  1. IRIS-KS immune reconstitution inflammatory syndrome-Kaposi’s sarcoma, CR complete response, PR partial response
  2. aOne patient abandoned treatment, had Kaposi’s sarcoma progression and died with AIDS and related comorbidities